Department of Urology, University of Illinois at Chicago, Chicago, Illinois, USA.
Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
J Endourol. 2024 Jul;38(7):668-674. doi: 10.1089/end.2024.0046. Epub 2024 May 3.
This study aimed to assess early outcomes of the single port (SP) robotic low anterior access (LAA) for all upper urinary tract surgeries. In addition, it aimed to explore the impact of clinical factors, notably Body Mass Index (BMI), on post-operative outcomes and length of hospital stay. Overall, 76 consecutive patients underwent SP robotic surgery with LAA involving all upper urinary tract pathologies, with data collected prospectively. Baseline characteristics, intra- and post-operative outcomes, pain levels, and opioid use were analyzed. Statistical methods, including logistic regression and locally weighted scatterplot smoothing analysis, were used to assess same-day discharge (SDD) predictors and the association between BMI and SDD probability. According to the Institutional Review Board (IRB) protocol, only data recorded in our electronic medical record system was included. Ten different procedures were performed with LAA, with no need for conversion to open surgery and complication rates in line with the literature (30 days: 5%, 90 days: 6.6%). Notably, 77.6% of patients were discharged on the same day. A significant association was found between BMI and prolonged hospital stay, particularly in obese patients (BMI ≥30 kg/m). Post-operative pain was generally low (median VAS: 4), with over 70% discharged without opioid prescriptions. The novel LAA is a versatile approach for various upper urinary tract surgeries, including in obese patients. While achieving satisfactory post-operative outcomes, increased BMI correlated with a reduced likelihood of SDD. Further studies, including larger cohorts and multicenter collaborations, are warranted to explore anesthesiologic management and validate these findings.
本研究旨在评估单端口(SP)机器人辅助下经低位前入路(LAA)治疗所有上尿路手术的早期结果。此外,还旨在探讨临床因素,特别是体重指数(BMI),对术后结果和住院时间的影响。 共 76 例连续患者接受了涉及所有上尿路病变的 SP 机器人辅助 LAA 手术,前瞻性收集数据。分析了基线特征、围手术期结果、疼痛程度和阿片类药物使用情况。使用逻辑回归和局部加权散点平滑分析等统计方法来评估当天出院(SDD)的预测因素以及 BMI 与 SDD 概率之间的关系。根据机构审查委员会(IRB)的方案,仅纳入我们电子病历系统中记录的数据。 进行了 10 种不同的 LAA 手术,无需转为开放手术,并发症发生率与文献相符(30 天:5%,90 天:6.6%)。值得注意的是,77.6%的患者当天出院。BMI 与住院时间延长显著相关,尤其是肥胖患者(BMI≥30kg/m)。术后疼痛通常较低(中位数 VAS:4),超过 70%的患者无需开具阿片类药物处方即可出院。 新型 LAA 是一种治疗各种上尿路手术的多功能方法,包括肥胖患者。在实现令人满意的术后结果的同时,BMI 增加与 SDD 可能性降低相关。需要进一步的研究,包括更大的队列和多中心合作,以探索麻醉管理并验证这些发现。